Open AllClose All

Robert W. Azelby , , Director Since March 2024 , , Retired President and Chief Executive Officer of Eliem Therapeutics Inc.

  • President and Chief Executive Officer of Eliem Therapeutics Inc., a biotechnology company focused on neuronal excitability disorders, from 2020 until 2023
  • President and Chief Executive Officer of Alder BioPharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on prevention of chronic migraines, from 2018 until company was acquired by Lundbeck in 2019
  • Executive Vice President and Chief Commercial Officer of Juno Therapeutics Inc., a biopharmaceutical company, from 2015 until the company was acquired by Celgene in 2018
  • Held various senior roles at Amgen, a multinational biopharmaceutical company, from 2000 until 2015
  • Other current public company directorships:
    • ADC Therapeutics SA, a commercial-stage biotechnology company since 2023
    • Autolus Therapeutics plc, a CAR T cell therapy company, since January 2024
  • Prior public company directorships within the last five years:
    • Chinook Therapeutics Inc., a clinical-stage biopharmaceutical company, from 2023 until the company was acquired later in 2023
    • Eliem Therapeutics Inc., a biotechnology company, from 2020 until 2023
    • Clovis Oncology Inc., a pharmaceutical company, from 2018 until 2022
    • Immunomedics, a biotechnology company, from 2020 until the company was acquired later in 2020
    • Alder BioPharmaceuticals Inc., a clinical-stage biopharmaceutical company, from 2018 until the company was acquired in 2019

Steven K. Barg , , Director Since September 2022 , , Global Head of Engagement, Elliott Management Corporation

  • Global Head of Engagement of Elliott Management Corporation, an investment management firm and affiliate of Elliott Investment Management L.P., since 2020
  • Chief Financial Officer of Elliott Opportunity II Corp., a special purpose acquisition company sponsored by an affiliate of Elliott Investment Management L.P., from 2021 until 2023
  • Participating managing Director of The Goldman Sachs Group Inc., an investment bank and financial services company, from 2010 until 2019
  • Other current public company directorships: Catalent, Inc., a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products, since September 2023

Michelle M. Brennan , , Director Since September 2022 , , Retired Value Creation Leader, Johnson & Johnson

  • Global Value Creation Leader of Johnson & Johnson, a researcher, developer, and manufacturer in the healthcare and consumer packaged goods fields, from 2019 to 2020 and Company Group Chair of Medical Devices in Europe, the Middle East, and Africa, from 2015 to 2018
  • Other current public company directorships: Masimo Corporation, a global medical technology company, since June 2023
  • Prior public company directorships within the last five years: Coupa Software Incorporated, a global technology platform for Business Spend Management, from 2020 until 2023

Sujatha Chandrasekaran , , Director Since September 2022 , , Former Senior Executive Vice President and Chief Digital and Information Officer, CommonSpirit Health

  • Senior Executive Vice President and Chief Digital and Information Officer of CommonSpirit Health, a non-profit health system, from 2019 to 2022
  • Global Chief Information Officer of Kimberly-Clark Corporation, a multinational personal care corporation focused on consumer tissue and paper products, from 2016 to 2019
  • Senior Vice President, Global Chief Technology and Data Officer for Walmart Inc., an American multinational retail corporation, from 2011 to 2016
  • Other current public company directorships:
    • American Eagle Outfitters, an American lifestyle, clothing, and accessories retailer, since 2018
    • Brenntag SE, a global chemical distribution company, since June 2023
    • Atos, a multinational information technology service and consulting company, since January 2024
  • Prior public company directorships within the last five years: Barry Callebaut AG, a Swiss-Belgian cocoa processor and chocolate manufacturer, from 2018 to 2020

Sheri H. Edison , , Director Since 2020 , , Retired Executive Vice President and General Counsel, Amcor plc

  • Executive Vice President and General Counsel, Amcor plc, a global packaging company, since 2019 until her retirement in 2021
  • Senior Vice President, Chief Legal Officer and Secretary, Bemis Company, Inc. (“Bemis”), a global packaging company, from 2017 until Bemis was acquired by Amcor in 2019
  • Vice President, General Counsel and Secretary, Bemis from 2010 to 2016
  • Senior Vice President and Chief Administrative Officer, Hill-Rom Holdings, Inc., a global medical device company, from 2007 to 2010
  • Other current public company directorships: Union Pacific Corporation, a freight-hauling railroad franchise, since 2021
  • Prior public company directorships within the last five years: AK Steel Holding Corporation, a steel manufacturer, from 2014 to 2020

David C. Evans , , Director Since 2020 , , Retired Executive Vice President and Chief Financial Officer, The Scotts Miracle-Gro Company

  • Executive Vice President and Chief Financial Officer, Battelle Memorial Institute, a private research and development organization, from 2013 to 2018
  • Executive Vice President and Chief Financial Officer, The Scotts Miracle-Gro Company, a consumer lawn and garden products company, from 2006 to 2013 and Executive Vice President, Strategy and Business Development from 2011 to 2013
  • Interim Chief Financial Officer, The Scotts Miracle-Gro Company, a consumer lawn and garden products company, from August 2022 to December 2022
  • Interim Chief Financial Officer, Cardinal Health, from 2019 to 2020
  • Other current public company directorships: The Scotts Miracle-Gro Company since 2018

Patricia A. Hemingway Hall , , Director Since 2013 , , Retired President and Chief Executive Officer, Health Care Service Corporation

  • President and Chief Executive Officer of Health Care Service Corporation, a mutual health insurer, from 2008 until her retirement in 2016
  • President and Chief Operating Officer of Health Care Service Corporation from 2007 to 2008
  • Other current public company directorships: ManpowerGroup Inc., a staffing services company, since 2011
  • Prior public company directorships within the last five years:
    • Celgene Corporation, a biopharmaceutical company, from 2018 to 2019
    • Halliburton Company, a provider of products and services to the energy industry, from 2019 to 2022

Jason M. Hollar , , Director Since September 2022 , , Chief Executive Officer, Cardinal Health

  • Chief Executive Officer of Cardinal Health, since September 1, 2022
  • Chief Financial Officer of Cardinal Health from 2020 to 2022
  • Executive Vice President and Chief Financial Officer of Tenneco Inc., a global automotive products and services company, from 2018 to 2020
  • Senior Vice President Finance at Tenneco Inc. from 2017 to 2018
  • Chief Financial Officer of Sears Holding Corporation, a holding company for large consumer retailers across the U.S., from 2016 to 2017
  • Other current public company directorships: DaVita Inc., owns and operates outpatient medical care centers across the country, focusing on dialysis and kidney care, since May 2022

Akhil Johri , , Director Since 2018 , , Retired Executive Vice President and Chief Financial Officer, United Technologies Corporation; Operating Advisor to Clayton, Dubilier & Rice

  • Executive Vice President and Chief Financial Officer, United Technologies Corporation, a provider of high technology products and services to the building systems and aerospace industries, from 2015 to 2019
  • Operating Advisor to Clayton, Dubilier & Rice, a global private equity manager, since 2021
  • Chief Financial Officer and Chief Accounting Officer of Pall Corporation, a global supplier of filtration, separations and purification products, from 2013 to 2014
  • Vice President of Finance and Chief Financial Officer, United Technologies: UTC Propulsion & Aerospace Systems, from 2011 to 2013
  • Other public company directorships: The Boeing Company, a multinational corporation that designs, manufactures, and sells airplanes, rotorcraft, rockets, satellites, telecommunications equipment, and missiles worldwide, since 2020

Gregory B. Kenny , , Director Since 2007 and Independent Chairman since 2018 , , Retired President and Chief Executive Officer, General Cable Corporation

  • President and Chief Executive Officer of General Cable Corporation, a global manufacturer of aluminum, copper, and fiber-optic wire and cable products, from 2001 to 2015
  • Other current public company directorships: Ingredion Incorporated (formerly Corn Products International, Inc.), a corn refining and ingredient company, since 2005
  • Prior public company directorships within the last five years: AK Steel Holding Corporation, a steel manufacturer, from 2016 to 2020

Nancy Killefer , , Director Since 2015 , , Retired Senior Partner, Public Sector Practice, McKinsey & Company, Inc.

  • Senior Partner of McKinsey & Company, Inc., a global management consulting firm, from 1992 to 2013
  • Assistant Secretary for Management, Chief Financial Officer and Chief Operating Officer for the U.S. Department of Treasury from 1997 to 2000
  • Other current public company directorships:
    • Certara, Inc., a global leader in biosimulation, since 2021
    • Meta Platforms, Inc., an American online social media and social networking service, since 2020
  • Prior public company directorships within the last five years:
    • Avon Products, Inc., a global manufacturer and marketer of beauty products, from 2013 to 2020
    • Taubman Centers, Inc., a real estate investment trust engaged in the ownership, management and leasing of shopping centers, from 2019 to 2020
    • Natura & Co, a Brazilian global personal care cosmetics group, from 2020 to 2023

Christine A. Mundkur , , Director Since September 2022 , , Retired Chief Executive Officer, Impopharma, Inc.

  • Chief Executive Officer and non-voting Chair of the Board of Directors of Impopharma Inc., a generic pharmaceutical inhalation development company, from 2013 to 2017
  • President of CM Strategic Advisors, consulting on global pharmaceutical business strategies, from 2011 to 2013
  • President and Chief Executive Officer of the U.S. Division and Head of Commercial Operations for North America for Sandoz Inc., a division of the Novartis Group, and a global generic and biosimilar pharmaceutical business, from 2009 to 2010
  • Chief Executive Officer of Barr Laboratories Inc., a subsidiary of Barr Pharmaceuticals Inc., in 2008 until Barr Pharmaceuticals was acquired by Teva Pharmaceutical Industries Ltd.
  • Other current public company directorships: MannKind Corporation, a global biopharmaceutical company focused on treatments for diabetes, since November 2018
  • Prior public company directorships within the last five years: Lupin Limited, an Indian multinational pharmaceutical company, from 2019 to 2022

Communicate with the Board

Shareholders and other interested parties may communicate with the Board, any committee of the Board, any individual director, or the independent directors as a group, by writing to the Office of the Corporate Secretary, Cardinal Health, Inc., 7000 Cardinal Place, Dublin, Ohio 43017, or sending an e-mail to bod@cardinalhealth.com Communications from shareholders will be distributed to the entire Board unless addressed to a particular committee or director. The Corporate Secretary will not distribute communications that are unrelated to the duties of the Board, such as spam, junk mail, mass mailings, business solicitations, and advertisements.

Cardinal Health © 2013 Cardinal Health. All rights reserved.